Study: Assay Can Detect Cancer Relapse up to 2 Years Earlier than Imaging
In a UK study, the Signatera molecular residual disease assay detected disease relapse up to 2 years prior to detection via imaging, with zero false positives.
Read MoreSearch Results for: liver disease
GenePOC Carba Test Receives CE Mark
The assay is intended to help stop the spread and transmission of carbapenem-producing organisms.
Read More
May 2019 Product Spotlight: Anatomic and Digital Pathology Instruments and Tools
The May 2019 Product Spotlight includes anatomic and digital pathology instruments and analyzers from companies such as OptraScan, Proscia, and BioGenex Laboratories.
Read More
Managing Reagent Variation
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Read More
Inside Track: Concussion Diagnostics
Developers are exploring the potential of blood biomarkers for traumatic brain injury.
Read More